Decoy Therapeutics is trading 8.31% down at $3.53, with the warrant-inducement financing creating the clearest pressure.

  • Shares are pulling back after rallying to $3.85 on September 23, 2026.
  • The $3.85 million financing involved discounted $3.25 warrant exercises and new warrants for up to 2,368,868 shares, increasing potential dilution; a September 23 correction said the new warrants are exercisable immediately upon issuance.
  • Broader biotechnology weakness and rising yields also add pressure.